US President Trump reportedly pressures FDA commissioner to approve flavoured vapes (PM, MO), via WSJ
Context
The reported pressure from President Trump on the FDA to approve flavored vapes could signal a shift in regulatory stance, impacting major tobacco companies like Altria Group. This intervention may affect investor sentiment in related sectors, with potential ripple effects across equities and commodities, particularly if it alters perceptions on health regulation and consumer markets.
Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.
Open Dashboard#UNITED STATES#USD#EUR#JAPAN#JPY#UNITED KINGDOM#GBP#ASIA#EUROPE#ALTRIA GROUP INC#FDA#IMPORTANT#FOREX#EQUITIES#ENERGY#EU SESSION#US SESSION#DOW JONES INDUSTRIAL AVERAGE#WTI#COMMODITIES#GOLD#TOBACCO#TOBACCO (GROUP)#FOOD, BEVERAGE & TOBACCO#S&P 500 INDEX#NASDAQ 100 INDEX#MO#BRENT CRUDE#DXY#TRUMP#US EQUITIES